A5063624064- Diet and metabolism studies
- Bariatric Surgery and Outcomes
- Diabetes Management and Research
- Nutrition and Health in Aging
- Body Contouring and Surgery
- Diabetes Treatment and Management
- Metabolism, Diabetes, and Cancer
- Bioactive Compounds and Antitumor Agents
- Receptor Mechanisms and Signaling
- Chronic Kidney Disease and Diabetes
- Gut microbiota and health
- Clostridium difficile and Clostridium perfringens research
- Muscle metabolism and nutrition
- Pharmacology and Obesity Treatment
Hospital do Servidor Público Estadual
2020-2024
Faculdade de Ciências Médicas da Santa Casa de São Paulo
2024
Irmandade da Santa Casa de Misericórdia de São Paulo
2010
SUMMARY Introduction Obesity is a chronic, prevalent, multifactorial disease, stigmatized and linked to multiple long-term complications, which makes the treatment currently available below of expectations from what necessary combat it. Because this limitation, off-label medications for obesity, such as topiramate, have been widely used, in association with on-label medications, sibutramine, order achieve more effective weight loss. Objective Compare effectiveness combination sibutramine...
Introduction Type 2 diabetes mellitus (T2DM) is associated with dysbiosis in the gut microbiota (MB). Individually, each medication appears to partially correct this. However, there are no studies on response of MB changes A1c. Therefore, we investigated MB’s intensive glycemic control. Research design and methods We studied two groups patients uncontrolled T2DM, one group an A1c <9% (18 patients—G1) another >9% (13 patients—G2), aiming for at least a 1% reduction collected fecal...
BACKGROUND: There is a debate over results obtained from type 2 diabetes mellitus (DM2) obese patients and non-DM2 patients, in reference to metabolic control ponderal loss, after bariatric surgery. AIM: To evaluate weight loss profile of with DM2 versus subjects, one three years METHODS: Data 38 44 submitted Roux-en-Y gastric-bypass were analysed retrospectively. For the pre-operatory, first third year post-operatory, compared: weight, body mass index (BMI), fasting glucose (FG), high...
Abstract Background and aims: The physiopathology of hyperinsulinemic hypoglycemia (HH) after gastric bypass (GB) is not well understood, although it a common adverse event this procedure. fast absorption glucose meal, the high variability, increase in glucagon peptide 1 secretion or hyperplasia beta cell have been postulated as possible hypothesis. Mixed Meal Tolerance test (MMT) used clinical practice during HH investigation, but there no consensus for diagnosis bariatric surgery. In...